07.07.20

Regeneron Advances Double Antibody Cocktail Into Phase 3 COVID-19 Prevention Study

Source: FirstWord

06.25.20

US Sues Regeneron Over Alleged Kickbacks for Eylea

Source: FirstWord

06.23.20

How Regeneron’s COVID-19 Antibody Cocktail Cuts the Risk of Resistance

Source: FierceBiotech

05.12.20

Regeneron CEO: Manufacturing Not Up to Snuff for COVID-19 Vaccines, Therapies

Source: FiercePharma

04.28.20

Sanofi/Regeneron and Roche Report Mixed Results for Potential COVID-19 Treatments

Source: FirstWord

04.16.20

FDA Grants Priority Review Approval For Regeneron’s REGN-EB3 to Treat Ebola

Source: Regeneron

04.01.20

Retina Industry Giants Temporarily Extend Payment Terms

Source: Eyewire News

03.26.20

Regeneron to Extend Payment Terms for Eylea (Aflibercept) Injection

Source: American Academy of Ophthalmology

03.18.20

Regeneron’s Novel COVID-19 Antibody Program Has Potential to Enter Human Clinical Studies by Early Summer

Source: Regeneron Pharmaceuticals

12.10.19

Eylea Injection Prefilled Syringe Now Available

Source: Regeneron Pharmaceuticals

View more stories